Literature DB >> 22944336

The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder.

B J Hasselbalch1, U Knorr, S G Hasselbalch, A Gade, L V Kessing.   

Abstract

OBJECTIVE: To investigate whether the cumulative number, duration and subtypes (severity and presence of psychotic features) of previous episodes of depression in patients with unipolar depressive disorder in a remitted state are associated with decreased global cognitive function.
METHODS: Via the Danish registers individuals between 40 and 80 years of age were identified: (1) patients with a diagnosis of unipolar disorder at their first discharge from a psychiatric hospital in the period 1994 to 2002, and (2) gender and age matched control individuals. The participants were assessed with the Cambridge Cognitive Examination (CAMCOG), which provides a composite measure of global cognitive function.
RESULTS: A total of 88 patients and 50 controls accepted our invitation to participate, fulfilled the selection criteria and were included in the study. The cumulative duration of depressive episodes was associated with a decreased CAMCOG score adjusted for age, gender, education, premorbid IQ and residual depressive symptoms (B=-0.14, 95% C.I. (-0.26, -0.02), R(2)adj=0.31, P=.02). Significant associations were also found between CAMCOG score and the cumulative duration and total number of depressive episodes with psychotic features, respectively.
CONCLUSION: Our findings suggest that cognitive dysfunction is associated with the cumulative duration of depressive episodes, and that, in particular, depressive episodes with psychotic features in the course of illness may be a significant predictor of future impairment of cognitive function.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adolescent psychiatry; Affective disorder; Neuropsychology; Neuroscience; Unipolar depression

Mesh:

Year:  2012        PMID: 22944336     DOI: 10.1016/j.eurpsy.2012.03.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  14 in total

1.  Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.

Authors:  Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick
Journal:  CNS Spectr       Date:  2018-09-24       Impact factor: 3.790

Review 2.  Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Authors:  Raymond W Lam; Sidney H Kennedy; Roger S Mclntyre; Atul Khullar
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 3.  Measuring cognitive function in MDD: emerging assessment tools.

Authors:  Manuela Russo; Katie Mahon; Katherine E Burdick
Journal:  Depress Anxiety       Date:  2014-11-24       Impact factor: 6.505

4.  Effects of psychiatric history on cognitive performance in old-age depression.

Authors:  Alexandra Pantzar; Anna Rita Atti; Lars Bäckman; Erika J Laukka
Journal:  Front Psychol       Date:  2015-06-29

Review 5.  Major depressive disorder: mechanism-based prescribing for personalized medicine.

Authors:  Philip F Saltiel; Daniel I Silvershein
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-31       Impact factor: 2.570

6.  Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.

Authors:  Young Sup Woo; Joshua D Rosenblat; Ron Kakar; Won-Myong Bahk; Roger S McIntyre
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-02-29       Impact factor: 2.582

Review 7.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

8.  Aerobic exercise program with or without motor complexity as an add-on to the pharmacological treatment of depression - study protocol for a randomized controlled trial.

Authors:  Lucas Melo Neves; Carla Silva-Batista; Raquel Marquesini; Telma Fátima da Cunha; Elisa Dimateo; Luciana Nascimento; Acácio Moreira-Neto; Angelo Corrêa de Lima Miliatto; Sheila das Chagas Mendes; Flavia Saad; Jamile Sanches Codogno; Renato Hoffmann Nunes; Raphael Mendes Ritti-Dias; Valeria Juday; Beny Lafer; Carlos Ugrinowitsch
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

9.  Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?-A Perspective Paper.

Authors:  Lars Vedel Kessing; Kamilla Miskowiak
Journal:  Front Psychiatry       Date:  2018-10-08       Impact factor: 4.157

10.  Self-Reported Cognitive Function and Mental Health Diagnoses among Former Professional American-Style Football Players.

Authors:  Franziska Plessow; Alvaro Pascual-Leone; Caitlin M McCracken; Jillian Baker; Supriya Krishnan; Aaron Baggish; Ann Connor; Theodore K Courtney; Lee M Nadler; Frank E Speizer; Herman A Taylor; Marc G Weisskopf; Ross D Zafonte; William P Meehan
Journal:  J Neurotrauma       Date:  2019-12-10       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.